BiologybioRxiv

Ranked by formulaVerdict: Notable

Tetraspanin changes in septic blood are organized by cell type, with monocyte CD82 induction and leukocyte CD37 loss associated with mortality

Tetraspanins organize membrane domains that regulate inflammation.

By Wren, Ding, Zhang

Score█████░░░░░4.6

Caveats

  • Preprint; not yet peer reviewed.

VerdictWorth a reader's time today.

Read the originalPDF

Abstract

Background: Tetraspanins organize membrane domains that regulate inflammation. The antagonistic pair CD82 (pro-inflammatory, pro-leakage) and CD151 (anti-inflammatory, anti-leakage) coordinate endothelial activation and dysfunction in severe inflammation such as sepsis. Whether blood-cell tetraspanin networks are reorganized cell-type-specifically in human sepsis and relate to mortality is unknown. Methods: We integrated bulk meta-analysis (8 ICU-sampled cohorts, 241 controls, 550 sepsis), 28-day survival analysis (GSE65682, n=468), single-cell RNA-sequencing (3 datasets, 1.6 million PBMCs from 184 donors), co-expression networks (WGCNA), immune deconvolution with composition-adjusted survival, and mortality prediction models judged against matched random-gene controls. Mendelian randomization tested whether inherited variation in tetraspanin expression alters sepsis susceptibility. Single-cell RNA-sequencing of LPS-challenged mouse lung provided an orthogonal test. Results: Thirteen of 33 tetraspanins changed significantly in septic blood (up: CD63, CD82, CD151, ROM1, TSPAN9, UPK1A; down: CD81, TSPAN3, TSPAN13, TSPAN32, TSPAN18, TSPAN4, TSPAN31), and the direction of change followed myeloid versus lymphoid lineage restriction, reflecting the leukocyte composition shift of sepsis. WGCNA placed CD82 and CD151 in distinct modules. The CD82:CD151 ratio did not predict 28-day mortality (HR=1.09, p=0.37). In the discovery cohort, CD37 was the strongest survival-associated tetraspanin (HR=0.72 per SD, FDR=0.002), even after adjusting for leukocyte composition (HR=0.70, p=0.007). Single-cell analysis of three datasets resolved two cell-type-specific programs, monocyte CD82 up-regulation and pan-leukocyte CD37 loss. CD37 expression was directionally protective in all three independent ICU cohorts, significantly so only in the largest. Mendelian randomization found no evidence that genetically proxied baseline tetraspanin expression affects sepsis susceptibility (0 of 24 genes). In mouse lung, we found macrophage CD82 increased and endothelial CD151 decreased after LPS. Conclusions: Blood-cell tetraspanin networks are reorganized cell-type-specifically in sepsis. Much of the bulk signal reflects leukocyte composition rather than a coordinated membrane program. The CD82/CD151 antagonism, established in endothelium, is not captured by whole-blood ratios, in which the two genes reflect different cell types.

J. D. Wren, Y. Ding, X. A. Zhang

The editor's rubric

Heuristic review

Leverage3 / 5
A method or resource many groups across the field will adopt within a year.
24% of this desk’s rubric
Magnitude2 / 5
Solid incremental gain on a meaningful problem.
16% of this desk’s rubric
Evidence4 / 5
Strong: large scale, preregistered, independently replicated, or a well-powered randomized trial.
20% of this desk’s rubric
Novelty3 / 5
A genuinely new approach to an open problem.
20% of this desk’s rubric
Trajectory2 / 5
Some room to improve with obvious engineering.
10% of this desk’s rubric
Stakes3 / 5
Meaningful benefit to many people within a few years.
10% of this desk’s rubric

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: breadth (many tasks); novelty (alternative to status quo, discovery); design (randomized, meta-analysis); verification (p-value, multiple benchmarks, independent replication); stakes (global scale, mortality).

How the score was computed

rank-2026-10-18

Score█████░░░░░4.6

Score = 10 × (75% × adjusted merit / 10 + 15% × attention + 10% × freshness)

Desks place stronger verdicts first, then use this score to order work within the same verdict.

Merit
5.9 / 10
Weighted rubric, evidence-gated.
Adjusted merit
4.9 / 10
Shrunk toward the desk prior by editor confidence (50%).
Attention
0%
Citations, upvotes, points, mentions.
Freshness
88%
Half-life decay since publication.

No attention signals recorded yet.

The record

  • Reviewed by heuristic-v7 on Oct 21, 2026, 05:48 UTC. Paper type: clinical.
  • Categories: immunology
  • TOP, No.6 in the Medicine edition of October 21, 2026.
  • LEAD, No.1 in the Biology edition of October 21, 2026.